- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
| Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
|---|---|---|---|---|---|---|
| Associate Director, R&D Executive Communications and Storytelling | Cambridge (USA) | USA | Corporate Affairs | CTS | Communications & Public Affairs | Jan 03, 2025 |
| Director, Portfolio Advocacy LaCan | INSURGENTES | Mexico | People & Organization | Innovative Medicines | Communications & Public Affairs | Dec 18, 2024 |
| Director, Policy LaCan | INSURGENTES | Mexico | People & Organization | Innovative Medicines | Communications & Public Affairs | Dec 18, 2024 |
| Executive Director, Public Affairs WEC | Basel (City) | Switzerland | Corporate Affairs | Corporate | Communications & Public Affairs | Dec 16, 2024 |
| Executive Director, Public Affairs (SERCE Czech Republic, Hungary, Poland, Russia, ECC) | Basel (City) | Switzerland | Corporate Affairs | Corporate | Communications & Public Affairs | Dec 16, 2024 |
| Director of Communications and Media Engagement for Finance and Strategy & Growth organizations | Basel (City) | Switzerland | Corporate Affairs | CTS | Communications & Public Affairs | Dec 16, 2024 |
| Director, Strategy & Operations, Global Social Impact & Sustainability | Basel (City) | Switzerland | Corporate Affairs | Corporate | Communications & Public Affairs | Dec 16, 2024 |
| Head of Public Affairs, Ireland | Dublin (Country President Office (CPO)) | Ireland | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Dec 12, 2024 |
| Director, Emerging Policies Asia Pacific, Middle East and Africa(APMA) | Basel (City) | Switzerland | People & Organization | Corporate | Communications & Public Affairs | Dec 10, 2024 |
| Country Head, Comms & Patient Advocacy | Amsterdam | Netherlands | Corporate Affairs | CTS | Communications & Public Affairs | Dec 09, 2024 |
| Senior Manager, Owned Channel Strategy and Intelligence | Head Office (Japan) (Pharmaceuticals) | Japan | Corporate Affairs | CTS | Communications & Public Affairs | Dec 04, 2024 |
| Associate Director, Patient Engagement, Neuroscience and Gene Therapies | East Hanover | USA | Development | Innovative Medicines | Communications & Public Affairs | Dec 03, 2024 |
| Therapy Area Communications & Patient Advocacy & Disease Agnostic Lead, Spain | Barcelona Gran Vía | Spain | Corporate Affairs | CTS | Communications & Public Affairs | Dec 03, 2024 |
| Therapy Area Communications & Patient Advocacy Manager | Barcelona Gran Vía | Spain | Corporate Affairs | CTS | Communications & Public Affairs | Dec 03, 2024 |
| Senior Manager Portfolio Advocacy, Asia Pacific, Middle East and Africa(APMA) | Basel (City) | Switzerland | People & Organization | Corporate | Communications & Public Affairs | Dec 02, 2024 |
| Senior Manager Policy, Asia Pacific, Middle East and Africa(APMA) | Basel (City) | Switzerland | People & Organization | Corporate | Communications & Public Affairs | Dec 02, 2024 |
| Head, Portfolio Policy | East Hanover | USA | Corporate Affairs | Corporate | Communications & Public Affairs | Dec 02, 2024 |
| Manager, US Reputation & Corporate Storytelling | East Hanover | USA | Corporate Affairs | CTS | Communications & Public Affairs | Nov 26, 2024 |
| Lead - Government Affairs | Delhi (Office) | India | International | Innovative Medicines | Communications & Public Affairs | Nov 26, 2024 |
| Vice President of European Public Affairs | Brussels | Belgium | Corporate Affairs | Innovative Medicines | Communications & Public Affairs | Nov 14, 2024 |
| Communications & Patient Advocacy Sr. Specialist (1 yr contract) | Seoul | South Korea | Corporate Affairs | CTS | Communications & Public Affairs | Nov 13, 2024 |
| Public Affairs Manager | Ankara Gimat | Türkiye | International | Innovative Medicines | Communications & Public Affairs | Sep 13, 2024 |
| Public Affairs Manager (m/f/d) | Berlin West (Non-Sales Force) (Novartis Pharma GmbH) | Germany | International | Innovative Medicines | Communications & Public Affairs | Jul 09, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى